Illegal and Ineffective Disinfectants in the EU Market
20 EU countries have reported to the European Chemicals Agency (ECHA) and the European Commission (EC) that the COVID-19 pandemic has led to an increased number of non-compliant hand disinfectants on their markets since March 2020.
Liliana Teles

Liliana Teles

Regulatory Affairs Manager

In the context of the COVID-19 crisis, European States are encouraged to apply derogations to the normal product authorisation requirements of the Biocidal Products Regulation (BPR) to speed up the placement on the market of disinfectants and ensure that healthcare professionals and citizens have timely access to these products. The high demand for disinfectants to fight COVID-19 and the granting by Member States of health emergency permits have attracted new producers and suppliers to the market which often lack the regulatory knowledge of the applicable legal framework concerning safety and efficacy of these type of products.

Reports from EU Member States included:

– Disinfectants that do not have the required authorisation or permit

– Disinfectants that lack hazard labelling

– Products claiming to be disinfectants but which had a formulation that cannot be sufficiently effective against viruses, for example, due to insufficient concentrations of active substances with virucidal activity.

What happens when a product claimed to be a disinfectant is found to be illegal or counterfeit?

When EU Member States deem these products to pose a serious risk to the health of consumers, they communicate the measures taken against them in the Rapid Alert System for Non-Food Products (RAPEX).

National competent authorities are taking action, including fines and the withdrawal of the products from the market, to protect citizens from the risks of illicit and ineffective hand disinfectants being used to prevent the spread of COVID-19 and continue to perform inspections, including of online sales.

In March 2020, the unit in charge of fighting against counterfeit goods and illicit trade in the European Anti-Fraud Office (OLAF) has launched an enquiry into illicit trafficking of COVID-19 related products, including disinfectants.

References:

European Chemicals Agency – EU Member States report illegal and ineffective disinfectants – ECHA/NR/20/17 https://echa.europa.eu/pt/-/eu-member-states-report-illegal-and-ineffective-disinfectants

further
reading

drug_device_combination_1
medical devices

Regulatory Framework of Drug-Device Combination

The advances in technology continue to merge different types of products and the historical lines of separation between medical devices and medicinal products are getting thinner. Products combining medicinal products and medical devices are regulated either by Regulation (EU) 2017/745 (MDR) or by Directive 2001/83/EC.

Read More »
cosmetic products

SCCS Preliminary Opinion on Alpha-Arbutin and Beta-Arbutin

Alpha-arbutin and Beta-arbutin are used in cosmetic with antioxidant, bleaching and skin conditioning functions. Following concerns raised during discussion within the Working Group on Cosmetic Products and consequent call for data on these ingredients, the SCCS assessed the safety of Alpha-arbutin and Beta-arbutin in cosmetic products.

Read More »
cosmetic products

Request for SCCS Scientific Opinion on Citral

The European Commission requested the SCCS to assess whether the derived safe use levels for Citral by the application of the QRA2 based on the induction of skin sensitization is adequate to protect consumers. A period of 9 months was set for issuing the scientific opinion.

Read More »
cosmetic products

SCCS Scientific Advice on the Safety of Triclocarban and Triclosan

The European Commission Scientific Committee on Consumer Safety (SCCS) has published its preliminary version of the scientific advice on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products. The deadline for comments was set at 27 May 2022.

Read More »
cosmetic products

Cosmetic Regulation in the Andean Community

In the Andean Community (Bolivia, Colombia, Ecuador and Peru), cosmetic products are mainly regulated by Decision 833. All cosmetic products made available in these countries must undergo a Mandatory Sanitary Notification (NSO) and need to be manufactured according to Good Manufacturing Practices (GMP).

Read More »
cosmetic products

Cosmetic Product Labelling in the European Union

The Regulation (EC) No 1223/2009 lays down the mandatory information that needs to be included in the packaging and container of a cosmetic products. In addition to this information, most cosmetic products include certain claims, which must be supported and properly substantiated.

Read More »
cosmetic products

Environmental Claims in the UK

Green claims are a trend among consumer goods and services. We often see claims like ‘clean beauty’, ‘environmental friendly’ and so many others. But how can companies ensure that these claims are not misleading? The UK’s Competition and Markets Authority (CMA) has published its Green Claims Code, in order to help companies comply with legal obligations when making environmental claims.

Read More »
cosmetic products

Parabens in Cosmetic Products

Parabens are widely used as preservatives in cosmetic and personal care products. Over the years, there have been some concerns related to the safety of parabens. The SCCS has published several opinions regarding the use of these ingredients in cosmetics, indicating the concentration levels they considered safe for human health. In the EU, some parabens can be safely used as preservatives, while others are prohibited in cosmetic products.

Read More »
cosmetic products

The Product Information File (PIF)

A Product Information File (PIF) is mandatory for all cosmetic products placed in the European Union market. It is a document that compiles the technical information of the cosmetic product and it must be kept for a period of 10 years by the Responsible Person.

Read More »